Dr Reddy’s proposal comes after the USFDA granted remdesivir full regulatory status – making it the first COVID-19 drug to receive full approvalCOVID-19 treatment | DGCI rejects Dr Reddy’s application for full market authorisation for remdesivir: Report
ByBinary Squad
Nov 3, 2020 Dr Reddy’s proposal comes after the USFDA granted remdesivir full regulatory status – making it the first COVID-19 drug to receive full approval